Search

Your search keyword '"Lanreotide -- Forecasts and trends"' showing total 7 results
Start Over Descriptor "Lanreotide -- Forecasts and trends" Publisher comtex news network, inc.
7 results on '"Lanreotide -- Forecasts and trends"'

1. Rapid Growth Projected For Acromegaly Market At A CAGR Of More Than 18% Through 2024-2028 As Per The Business Research Company's Acromegaly Global Market Report 2024

Subjects
Business information services -- Forecasts and trends, Business -- Research, Lanreotide -- Forecasts and trends, Acromegaly -- Forecasts and trends, Company growth, Business database, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

LONDON, March 13, 2024 (GLOBE NEWSWIRE) -- As per The Business Research Company's Acromegaly Global Market Report 2024, the acromegaly market is on a rapid growth trajectory, with substantial increases [...]

Published
2024

2. COMP Adopts Positive Opinion on Orphan Designation for Mycapssa(R) for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors

Subjects
Tumors -- Care and treatment, Lanreotide -- Forecasts and trends, Orphan drugs -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business, European Union, European Union. European Commission, Mycapssa (Medication)
Abstract

COMP Adopts Positive Opinion on Orphan Designation for Mycapssa(R) for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors DUBLIN, Ireland, and Boston MA, December 19, 2022 Amryt (Nasdaq: AMYT), [...]

Published
2022

3. European Commission approves Mycapssa(R) for the treatment of Acromegaly

Subjects
Lanreotide -- Forecasts and trends, Drug approval -- Forecasts and trends, Acromegaly -- Care and treatment, Market trend/market analysis, Banking, finance and accounting industries, Business, European Union, European Union. European Commission, Mycapssa (Medication)
Abstract

European Commission approves Mycapssa(R) for the treatment of Acromegaly Mycapssa(R) will be the first and only oral somatostatin analog approved in the EU Approval based on MPOWERED Phase 3 trial [...]

Published
2022

4. Auto-Injectors Market Is Estimated to Grow At CAGR of 16.60%, 2022-2030 | Latest Industry Coverage By Growth Plus Reports

Subjects
Rheumatoid factor -- Growth, Lanreotide -- Forecasts and trends, Multiple sclerosis -- Forecasts and trends, Arthritis -- Forecasts and trends, Industrial research -- Forecasts and trends, Research and development, Company growth, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Pune, Nov. 24, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, ' https://www.globenewswire.com/Tracker?data=Hu5Yaoal14elm711hqTLPYo_vtowBdMlJp8OH-_WCkYr2tvSIxpz1SZAruWC_TsEiB0XGKPAys88dNPJ5oAoWQZicBnUXqZFQyNeFMtL8_h4O0EwNqpoXHWqgwtQIb6qObKQYcXVMEetbQLv6JBWFw== by Product Type (Disposable Auto-injectors, Reusable Auto-injectors), by Disease Indication (Rheumatoid Arthritis, Multiple [...]

Published
2022

5. COMP adopts positive opinion on Orphan Disease Designation for Mycapssa(R) for the treatment of Acromegaly

Subjects
Lanreotide -- Forecasts and trends, Orphan drugs -- Forecasts and trends, Acromegaly -- Care and treatment, Market trend/market analysis, Banking, finance and accounting industries, Business, European Union, Mycapssa (Medication)
Abstract

COMP adopts positive opinion on Orphan Disease Designation for Mycapssa(R) for the treatment of Acromegaly DUBLIN, Ireland, and Boston MA, October 18, 2022 Amryt (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical [...]

Published
2022

6. Global Somatostatin Analogs Market to Reach $8.5 Billion by 2027

Subjects
Lanreotide -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

New York, March 19, Mar 19, 2021 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Global Somatostatin Analogs Industry' - https://www.reportlinker.com/p06032950/?utm_source=GNW In addition to being a [...]

Published
2021

7. Worldwide Peptide Cancer Therapeutics Industry to 2026 - Featuring Novartis, Amgen and Pfizer Among Others

Subjects
Pfizer Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Lanreotide -- Forecasts and trends, Antineoplastic agents -- Forecasts and trends, Cancer -- Forecasts and trends, Peptides -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Antimitotic agents -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, March 17, Mar 17, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Global Peptide Cancer Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2026' report has been added to [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results